David Hoffman1, Robert Kringle. 1. Preclinical and Research Biostatistics, Sanofi-aventis, Bridgewater, New Jersey, USA.
Abstract
PURPOSE: Typical acceptance criteria for analytical methods are not chosen with regard to the concept of method suitability and are commonly based on ad-hoc rules. Such approaches yield unknown and uncontrolled risks of accepting unsuitable analytical methods and rejecting suitable analytical methods. This paper proposes a formal statistical framework for the validation of analytical methods, which incorporates the use of total error and controls the risks of incorrect decision-making. MATERIALS AND METHODS: A total error approach for method validation based on the use of two-sided beta-content tolerance intervals is proposed. The performance of the proposed approach is compared to the performance of current ad-hoc approaches via simulation techniques. RESULTS: The current ad-hoc approaches for method validation fail to control the risk of incorrectly accepting unsuitable analytical methods. The proposed total error approach controls the risk of incorrectly accepting unsuitable analytical methods and provides adequate power to accept truly suitable methods. CONCLUSION: Current ad-hoc approaches to method validation are inconsistent with ensuring method suitability. A total error approach based on the use of two-sided beta-content tolerance intervals was developed. The total error approach offers a formal statistical framework for assessing analytical method performance. The approach is consistent with the concept of method suitability and controls the risk of incorrectly accepting unsuitable analytical methods.
PURPOSE: Typical acceptance criteria for analytical methods are not chosen with regard to the concept of method suitability and are commonly based on ad-hoc rules. Such approaches yield unknown and uncontrolled risks of accepting unsuitable analytical methods and rejecting suitable analytical methods. This paper proposes a formal statistical framework for the validation of analytical methods, which incorporates the use of total error and controls the risks of incorrect decision-making. MATERIALS AND METHODS: A total error approach for method validation based on the use of two-sided beta-content tolerance intervals is proposed. The performance of the proposed approach is compared to the performance of current ad-hoc approaches via simulation techniques. RESULTS: The current ad-hoc approaches for method validation fail to control the risk of incorrectly accepting unsuitable analytical methods. The proposed total error approach controls the risk of incorrectly accepting unsuitable analytical methods and provides adequate power to accept truly suitable methods. CONCLUSION: Current ad-hoc approaches to method validation are inconsistent with ensuring method suitability. A total error approach based on the use of two-sided beta-content tolerance intervals was developed. The total error approach offers a formal statistical framework for assessing analytical method performance. The approach is consistent with the concept of method suitability and controls the risk of incorrectly accepting unsuitable analytical methods.
Authors: J W Findlay; W C Smith; J W Lee; G D Nordblom; I Das; B S DeSilva; M N Khan; R R Bowsher Journal: J Pharm Biomed Anal Date: 2000-01 Impact factor: 3.935
Authors: K J Miller; R R Bowsher; A Celniker; J Gibbons; S Gupta; J W Lee; S J Swanson; W C Smith; R S Weiner Journal: Pharm Res Date: 2001-09 Impact factor: 4.200
Authors: Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelley; JoMarie Smolec; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker Journal: Pharm Res Date: 2003-11 Impact factor: 4.200
Authors: Ph Hubert; J-J Nguyen-Huu; B Boulanger; E Chapuzet; P Chiap; N Cohen; P-A Compagnon; W Dewé; M Feinberg; M Lallier; M Laurentie; N Mercier; G Muzard; C Nivet; L Valat Journal: J Pharm Biomed Anal Date: 2004-11-15 Impact factor: 3.935
Authors: JoMarie Smolec; Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelly; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker; Vinod Shah; Ronald Bowsher; Anthony Mire-Sluis; John W A Findlay; Mary Saltarelli; Valerie Quarmby; David Lansky; Robert Dillard; Martin Ullmann; Stephen Keller; H Thomas Karnes Journal: Pharm Res Date: 2005-08-24 Impact factor: 4.200
Authors: Dany Spaggiari; Vincent Desfontaine; Sandra Cruchon; Sylvie Guinchard; Anthony Vocat; Emilyne Blattes; Jeff Pitteloud; Lorenzo Ciullini; Carine Bardinet; Anton Ivanyuk; Vadim Makarov; Olga Ryabova; Thierry Buclin; Stewart T Cole; Laurent A Decosterd Journal: PLoS One Date: 2019-05-31 Impact factor: 3.240